SESSION TITLE: Student/Resident Case Report Poster - Obstructive Lung Diseases
SESSION TYPE: Student/Resident Case Report Poster
PRESENTED ON: Tuesday, October 25, 2016 at 01:30 PM - 02:30 PM
INTRODUCTION: Roflumilast, a selective phosphodiesterase-4 inhibitor, is a well tolerated medication in the prevention of chronic obstructive pulmonary disease (COPD) exacerbations in patients with moderate to severe COPD. Roflumilast has infrequently been described as a cause of pancreatitis. We present a patient with Roflumilast induced pancreatitis, which resolved after discontinuation.